226 related articles for article (PubMed ID: 25888625)
1. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
[TBL] [Abstract][Full Text] [Related]
2. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
3. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
Cui X; Li Q; He Y
Mol Cell Biochem; 2017 Jan; 424(1-2):195-201. PubMed ID: 27822662
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
[TBL] [Abstract][Full Text] [Related]
5. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
Wang CM; Wang Y; Fan CG; Xu FF; Sun WS; Liu YG; Jia JH
Biochem Biophys Res Commun; 2011 Aug; 411(3):586-92. PubMed ID: 21763284
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
Bae HJ; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Chang YG; Shen Q; Kim SJ; Park WS; Lee JY; Nam SW
Oncogene; 2014 May; 33(20):2557-67. PubMed ID: 23728341
[TBL] [Abstract][Full Text] [Related]
7. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
[TBL] [Abstract][Full Text] [Related]
8. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
9. MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma.
Wu N; Liu X; Xu X; Fan X; Liu M; Li X; Zhong Q; Tang H
FEBS J; 2011 Jun; 278(12):2044-54. PubMed ID: 21481188
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma.
Che J; Su Z; Yang W; Xu L; Li Y; Wang H; Zhou W
Dig Liver Dis; 2023 Mar; 55(3):412-421. PubMed ID: 35853821
[TBL] [Abstract][Full Text] [Related]
14. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
15. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
Wang H; Chen W; Qi Y; Liu D; Liu Z; Zhang Q; Yi Y; Wang J; Wu W
Dig Dis Sci; 2023 May; 68(5):1923-1935. PubMed ID: 36583803
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
17. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
Li X; Zhang W; Zhou L; Yue D; Su X
Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
[TBL] [Abstract][Full Text] [Related]
19. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
Lang Q; Ling C
Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
